跳至主要内容
临床试验/ACTRN12616001078448
ACTRN12616001078448尚未招募3 期

Premedication and preparation for children with Autism Spectrum Disorder:A multi-centre randomised, blinded trial to determine the quality of induction using combination of low dose clonidine and midazolam versus placebo plus high dose of midazolam as premedication.

Murdoch Children Research Institute (MCRI)0 个研究点目标入组 114 人开始时间: 2016年8月10日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
114

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
4 Years 至 16 Years(—)
性别
All

入选标准

  • Diagnosed with ASD , between the ages of 4-16 years, ASA 1 or 2, No contraindication to premedication. Any type of operation is permitted. They are scheduled to undergo surgery.

排除标准

  • ASA 3 or 4, cardiac/ respiratory conditions that exclude the use of sedation, obesity with weight more than 95% for age or BMI >30 (whatever is lower), previous intolerance or allergy to either medication or formulation component, Gastrointestinal disorders that affect absorption.

研究者

发起方
Murdoch Children Research Institute (MCRI)

相似试验

A trial to compare the quality of induction using... | 临床试验